Search results
Tharimmune Announces 1-for-15 Reverse Stock Split
Morningstar· 5 hours agoBRIDGEWATER, NJ / ACCESSWIRE / May 22, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio ...
NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and...
WRBL Columbus· 4 hours agoNeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical ...
HC Wainwright Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX)
ETF DAILY NEWS· 4 days agoHC Wainwright reiterated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a research note released on Wednesday morning, Benzinga reports. The ...
Biogen to Pay Up to $1.8 Billion for Immune Drug Developer
Bloomberg· 4 hours agoHave a confidential tip for our reporters? Biogen Inc. agreed to acquire Human Immunology...
AltruBio Gathers Funds as Biotechs Aim for Next Blockbuster Anti-Inflammatory Therapy
The Wall Street Journal· 1 day agoBiotechnology startup AltruBio has secured fresh capital to develop a drug for ulcerative colitis as...
Is It Too Late to Buy Viking Therapeutics Stock?
Motley Fool via Yahoo Finance· 4 hours agoA share of just 10% would equate to $3.9 billion in annual revenue. Given that the stock's market capitalization is currently $8.6 billion and the ...
Eric J. Hyllengren Sells 28,648 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Stock
ETF DAILY NEWS· 10 hours agoAtara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) CFO Eric J. Hyllengren sold 28,648 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were ...
Wynwood’s tech office boom hits a short circuit
The Real Deal via Yahoo Finance· 2 hours agoR&B Realty’s Aron Rosenberg and Brick & Timber’s Jesse Feldman with The Gateway at Wynwood, Cube Wynwd and The Annex Wynwood (R&B Realty Group, LinkedIn,...
BIO to restructure, lay off staff in shakeup of lobbying group
BioPharma Dive via Yahoo Finance· 2 days agoThe Biotechnology Innovation Organization is restructuring after conducting a “thorough evaluation”...
Vivek Ramaswamy Acquires Activist Stake in BuzzFeed
The Hollywood Reporter via Yahoo Finance· 3 hours agoBuzzFeed has an activist investor, and it is a familiar name to close followers of Republican politics. Vivek Ramaswamy, the entrepreneur who ran an...
